Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 627

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 627
---
 of members of its board of directors with executives at other companies. The 2024 annual base salaries for its named executive officers are set forth in the table below:

| ​                      | ​ |          ​ |
| ​                      |   |       Base |
| Name                   |   | Salary ($) |
| Imran Alibhai, Ph.D.   |   |    551,050 |
| John Kauh, M.D.        |   |    412,000 |
| Dan Conn, J.D., M.B.A. |   |    381,100 |

Annual Performance Bonus Opportunity For 2024, Tvardi named executive officers were eligible to receive discretionary annual performance bonuses based on individual performance, company performance or as otherwise determined appropriate, as determined by its board of directors. For 2023 and 2024, each of Drs. Alibhai and Kauh and Mr. Conn were eligible to receive a target bonus equal to 50%, 30% and 30% of his base salary, respectively. In January 2024, the Tvardi board of directors approved and paid annual performance bonuses for Drs. Alibhai and Kauh and Mr. Conn in the amounts of $267,500, $110,466 and $111,000, respectively. In January 2025, the Tvardi board of directors approved and paid annual performance bonuses for Drs. Alibhai and Kauh in the amounts of $275,525 and $123,600, respectively. In recognition of Mr. Conn’s additional efforts in 2024 in connection with the Merger and the Convertible Note financing completed or entered into in 2024, the Tvardi board of directors approved and paid an annual performance bonus for Mr. Conn of $171,495. All such bonuses are reflected in the “Bonus” column of the Summary Compensation Table above. Equity-Based Incentive Awards Tvardi's equity award program is the primary vehicle for offering long-term incentives to its executive officers. Tvardi believes that equity awards provide its executives with a strong link to its long-term performance, create an ownership culture, help align the interests of its executives and its stockholders and promote retention of its executive officers and other employees. To date, Tvardi has used stock option grants for this purpose because it believes they are an effective means by which to align the long-term interests of its executive officers with those of its stockholders. Grants to executive officers and other